Septal Shift for the Diagnosis of COnstrictive Pericarditis: The Impact of

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

This study will evaluate the effect of deep breathing manoeuvres on inter ventricular interdependency physiology. By providing further insight in this basic physiology we want to add more comprehensive data in favor or not of constrictive pericarditis diagnostic criteria currently used in cardiovascular magnetic resonance.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT04623528` - Characterization of the Liver Parenchyma Using Parametric T1 and T2 Magnetic Resonance Relaxometry
	Withdrawn	`NCT02027350` - New Methods to Diagnose Constrictive Pericarditis	N/A

NCT number	NCT02685371
Study type	Observational
Source	Université de Sherbrooke
Contact	Farand Paul, M.D.
Phone	819-346-1110
Email	paul.farand@usherbrooke.ca
Status	Recruiting
Phase
Start date	September 2016
Completion date	February 2020

Septal Shift for the Diagnosis of COnstrictive Pericarditis: The Impact of Inspiratory Effort Quantification on Deep Breathing Manoeuvres — SCOPED

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms